Related by context. Frequent words. (Click for all words.) 71 Natalizumab 70 efficacy endpoint 69 ximelagatran 69 Ischemic 69 Phase Ib clinical 69 pharmacodynamic effects 69 Thrombolysis 69 Dasatinib 69 placebo controlled clinical 68 Fibrillex TM 68 prospectively defined 68 Phase III Clinical Trial 68 elotuzumab 68 Randomized controlled 68 placebo controlled Phase 68 Amrubicin 67 Pivotal Trial 67 PRADAXA 67 Percutaneous Coronary Intervention 67 Pivotal Phase 67 Pivotal Phase III 67 pharmacokinetic PK 67 phase IIb clinical 67 Pirfenidone 67 thromboembolic 67 tanespimycin 67 PROMACTA 66 Chronic Heart Failure 66 liver transplant recipients 66 Clinical Trial Results 66 Solid Tumors 66 Metastatic Melanoma 66 nonrandomized 66 Acute Myocardial Infarction 66 Atopic Dermatitis 66 Benign Prostatic Hyperplasia 66 TORISEL 66 Pioglitazone 66 Multicenter 66 eplerenone 66 phase IIa 66 Traficet EN 65 nab paclitaxel 65 TOLAMBA 65 arterial thrombosis 65 KRN# 65 forodesine 65 Diabetic Macular Edema 65 Monotherapy 65 Acute Coronary Syndrome 65 secondary efficacy endpoints 65 irbesartan 65 pertuzumab 65 romiplostim 65 Pulmonary Arterial Hypertension 65 tocilizumab 65 eltrombopag 65 chemoradiotherapy 65 platelet reactivity 65 Vandetanib 65 Cardiovascular Risk 65 tesmilifene 65 Hypoactive Sexual Desire Disorder 65 goserelin 65 Rosuvastatin 65 J Am Coll 65 alvimopan 65 mycophenolate mofetil 65 cangrelor 65 carotid artery stenting 65 substudy 65 GFT# 65 ZD# [001] 65 T2DM 65 NSABP 65 beta blocker therapy 65 axitinib 65 sipuleucel T 65 Bicifadine 65 TAXUS Stent 65 Lenalidomide 65 figitumumab 65 thromboembolism 64 platelet inhibition 64 mRCC 64 thromboembolic events 64 vorinostat 64 Eltrombopag 64 myocardial ischemia 64 Lu AA# 64 subgroup analyzes 64 colorectal carcinoma 64 INTEGRILIN 64 ILLUMINATE 64 ISTODAX 64 6R BH4 64 composite endpoint 64 neoadjuvant therapy 64 ATL# [001] 64 vandetanib 64 Anticoagulation